Oncoinvent ASA Balance Sheet

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	177.6	133.67	30.1	196.02	436.65
Cash & Short-Term Investments	177.6	133.67	30.1	196.02	436.65
Cash Growth	32.87%	344.15%	-84.65%	-55.11%	-39.49%
Accounts Receivable	0.99	0.45	-	-	-
Other Receivables	8.72	8.16	25.8	16.69	-
Total Trade Receivables	9.71	8.61	25.8	16.69	-
Other Current Assets	-	-	-	-	12.4
Total Current Assets	187.31	142.28	57.92	212.71	449.05
Net Property, Plant & Equipment	15.58	26.71	40.81	21.45	1.19
Other Long-Term Assets	2.07	2.03	4.05	-	-
Total Assets	204.96	171.02	98.73	234.16	450.24
Accounts Payable	15.07	14.74	12.75	7.7	26.73
Accrued Expenses	6.15	8.49	5.02	5.46	-
Current Portion of Leases	2.88	2.71	3.83	3.19	-
Other Current Liabilities	33.87	31.99	13.86	15.15	38.14
Total Current Liabilities	57.96	57.94	35.46	31.5	64.87
Long-Term Debt	-	-	-	-	0.94
Long-Term Leases	0.68	4.74	8.35	8.84	-
Total Long-Term Liabilities	0.68	4.74	8.35	8.84	0.94
Total Liabilities	58.63	62.68	43.8	40.35	65.81
Common Stock	223.92	9.22	1.94	1.94	8.85
Additional Paid-in Capital	57.42	735.87	549.55	544.96	375.58
Retained Earnings	-135.01	-636.76	-496.56	-353.08	-
Total Common Shareholders' Equity	146.33	108.33	54.93	193.82	384.43
Shareholders' Equity	146.32	108.33	54.93	193.82	384.43
Total Liabilities & Equity	204.96	171.02	98.73	234.16	450.24
Total Debt	3.55	7.45	12.17	12.03	0.94
Net Cash (Debt)	174.05	126.22	17.92	183.99	435.7
Net Cash Growth	37.90%	604.25%	-90.26%	-57.77%	-39.51%
Net Cash Per Share	1.41	5.05	1.25	209.18	495.36
Book Value	146.33	108.33	54.93	193.82	384.43
Book Value Per Share	1.18	4.34	3.84	220.35	437.06
Tangible Book Value	146.33	108.33	54.93	193.82	384.43
Tangible Book Value Per Share	1.18	4.34	3.84	220.35	437.06